Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free SIBN Stock Alerts

SiBone (SIBN) Financials

SiBone logo
$19.96 +0.48 (+2.46%)
As of 08/21/2026 04:00 PM Eastern
Compare
Annual Income Statements for SiBone

Annual Income Statements for SiBone

This table shows SiBone's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -23 -17 -38 -44 -57 -61 -43 -31 -18
Consolidated Net Income / (Loss)		 -23 -17 -38 -44 -57 -61 -43 -31 -19
Net Income / (Loss) Continuing Operations		 -23 -17 -38 -44 -57 -61 -43 -31 -19
Total Pre-Tax Income 		-23 -17 -38 -44 -57 -61 -43 -31 -19
Total Operating Income		 -17 -12 -36 -39 -52 -60 -47 -35 -22
Total Gross Profit		 43 51 61 64 80 91 109 132 160
Total Revenue		 48 55 67 73 90 106 139 167 201
Operating Revenue		 48 55 67 73 90 106 139 167 201
Total Cost of Revenue		 5.11 4.83 6.79 8.90 10 16 29 35 41
Operating Cost of Revenue		 5.11 4.83 6.79 8.90 10 16 29 35 41
Total Operating Expenses		 60 63 97 103 131 150 156 167 182
Selling, General & Admin Expense		 13 13 21 20 25 29 31 34 41
Marketing Expense		 42 44 68 74 94 108 110 117 124
Research & Development Expense		 5.51 5.38 7.28 9.46 12 14 15 17 17
Total Other Income / (Expense), net		 -5.69 -5.49 -2.40 -5.13 -4.90 -1.52 3.60 4.34 3.43
Interest Expense		 6.20 5.11 4.95 6.10 5.37 2.82 3.46 3.44 2.63
Interest & Investment Income		 0.18 0.77 2.55 1.10 0.19 1.30 6.92 7.85 6.07
Other Income / (Expense), net		 0.34 -1.15 -0.00 -0.13 0.28 - 0.14 -0.07 -0.02
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - - - - - 0.06 0.12 -0.56
Basic Earnings per Share		 ($6.65) ($2.20) ($1.55) ($1.50) ($1.71) ($1.79) ($1.13) ($0.75) ($0.44)
Weighted Average Basic Shares Outstanding		 3.47M 7.95M 24.71M 29.06M 33.15M 34.20M 38.43M 41.47M 42.96M
Diluted Earnings per Share		 ($6.65) ($2.20) ($1.55) ($1.50) ($1.71) ($1.79) ($1.13) ($0.75) ($0.44)
Weighted Average Diluted Shares Outstanding		 3.47M 7.95M 24.71M 29.06M 33.15M 34.20M 38.43M 41.47M 42.96M
Weighted Average Basic & Diluted Shares Outstanding		 3.47M 7.95M 24.71M 29.06M 33.84M 34.99M 41.06M 42.45M 44.17M
Cash Dividends to Common per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 - - $0.00 $0.00

Quarterly Income Statements for SiBone

This table shows SiBone's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -11 -11 -8.94 -6.58 -4.50 -6.39 -5.78 -4.57 -1.09 -4.49 -4.16
Consolidated Net Income / (Loss)		 -11 -11 -8.94 -6.58 -4.50 -6.54 -6.15 -4.57 -1.64 -4.33 -4.09
Net Income / (Loss) Continuing Operations		 -11 -11 -8.94 -6.58 -4.50 -6.54 -6.15 -4.57 -1.64 -4.33 -4.09
Total Pre-Tax Income 		-11 -11 -8.94 -6.58 -4.42 -6.54 -6.15 -4.54 -1.67 -4.33 -4.09
Total Operating Income		 -13 -12 -10 -7.63 -5.49 -7.48 -7.00 -5.38 -2.46 -5.09 -4.81
Total Gross Profit		 29 30 32 32 39 38 39 39 45 42 45
Total Revenue		 39 38 40 40 49 47 49 49 56 53 56
Operating Revenue		 39 38 40 40 49 47 49 49 56 53 56
Total Cost of Revenue		 10 8.00 8.39 8.44 10 9.60 9.82 9.81 12 11 11
Operating Cost of Revenue		 10 8.00 8.39 8.44 10 9.60 9.82 9.81 12 11 11
Total Operating Expenses		 41 42 42 40 44 45 46 44 47 47 49
Selling, General & Admin Expense		 8.08 8.18 8.33 8.10 9.15 9.96 11 10 9.83 10 10
Marketing Expense		 29 29 29 27 31 31 31 30 33 33 34
Research & Development Expense		 4.16 4.35 4.35 3.99 3.87 4.53 4.31 4.24 4.36 4.19 5.22
Total Other Income / (Expense), net		 1.38 1.14 1.14 1.06 1.08 0.94 0.85 0.85 0.79 0.76 0.72
Interest Expense		 0.89 0.88 0.88 0.88 0.80 0.66 0.67 0.67 0.63 0.59 0.60
Interest & Investment Income		 2.23 2.11 2.02 1.94 1.78 1.59 1.52 1.52 1.45 1.35 1.33
Other Income / (Expense), net		 - -0.09 0.00 0.01 - 0.01 -0.00 - - 0.00 -0.02
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - - - - -0.16 -0.37 - - 0.16 0.07
Basic Earnings per Share		 ($0.26) ($0.27) ($0.22) ($0.16) ($0.10) ($0.15) ($0.14) ($0.11) ($0.04) ($0.10) ($0.09)
Weighted Average Basic Shares Outstanding		 38.43M 40.93M 41.32M 41.72M 41.47M 42.34M 42.79M 43.19M 42.96M 43.96M 44.48M
Diluted Earnings per Share		 ($0.26) ($0.27) ($0.22) ($0.16) ($0.10) ($0.15) ($0.14) ($0.11) ($0.04) ($0.10) ($0.09)
Weighted Average Diluted Shares Outstanding		 38.43M 40.93M 41.32M 41.72M 41.47M 42.34M 42.79M 43.19M 42.96M 43.96M 44.48M
Weighted Average Basic & Diluted Shares Outstanding		 41.06M 41.20M 41.69M 41.94M 42.45M 42.61M 43.14M 43.39M 44.17M 44.35M 44.82M

Annual Cash Flow Statements for SiBone

This table details how cash moves in and out of SiBone's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -5.49 2.71 -15 43 9.84 -43 13 1.68 7.29
Net Cash From Operating Activities		 -18 -15 -32 -31 -40 -42 -19 -12 -0.68
Net Cash From Continuing Operating Activities		 -18 -15 -32 -31 -40 -42 -19 -12 -0.68
Net Income / (Loss) Continuing Operations		 -23 -17 -38 -44 -57 -61 -43 -31 -19
Consolidated Net Income / (Loss)		 -23 -17 -38 -44 -57 -61 -43 -31 -19
Depreciation Expense		 1.01 0.72 0.77 1.13 2.09 3.45 5.43 4.38 5.77
Amortization Expense		 0.29 0.05 -1.15 0.41 1.58 0.43 -3.80 -5.29 -2.93
Non-Cash Adjustments To Reconcile Net Income		 3.83 3.19 7.64 14 19 24 28 30 30
Changes in Operating Assets and Liabilities, net		 0.38 -1.03 -0.48 -2.53 -5.76 -7.96 -4.83 -10 -14
Net Cash From Investing Activities		 -0.48 -98 13 -63 52 -2.82 -60 13 4.16
Net Cash From Continuing Investing Activities		 -0.48 -98 13 -63 52 -2.82 -60 13 4.16
Purchase of Property, Plant & Equipment		 -0.48 -0.94 -2.45 -2.56 -6.39 -9.51 -7.80 -10 -8.41
Purchase of Investments		 0.00 -97 -144 -179 -102 -120 -189 -205 -193
Sale and/or Maturity of Investments		 - 0.00 160 119 160 126 138 229 205
Net Cash From Financing Activities		 13 115 3.49 136 -1.71 2.20 91 1.96 3.38
Net Cash From Continuing Financing Activities		 13 115 3.49 136 -1.71 2.20 91 1.96 3.38
Repayment of Debt		 -32 - 0.00 -47 -42 0.00 -35 -36 0.00
Issuance of Debt		 40 - 0.00 45 35 0.00 36 36 0.00
Issuance of Common Equity		 0.00 116 2.20 137 2.34 1.82 86 2.15 2.21
Other Financing Activities, net		 0.38 1.61 1.49 1.46 2.57 0.38 4.39 -0.15 1.17
Effect of Exchange Rate Changes		 -0.35 - - 0.32 -0.50 -0.43 0.13 -0.48 0.43
Cash Interest Paid		 4.51 5.50 4.95 4.28 3.23 2.62 3.26 3.35 2.53

Quarterly Cash Flow Statements for SiBone

This table details how cash moves in and out of SiBone's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -20 -1.23 -6.46 4.65 4.72 6.24 -7.04 -7.66 16 -8.71 -0.41
Net Cash From Operating Activities		 -2.30 -7.57 -6.33 0.30 1.18 -4.91 0.17 2.34 1.73 -2.36 0.78
Net Cash From Continuing Operating Activities		 -2.30 -7.57 -6.33 0.30 1.18 -4.91 0.17 2.34 1.73 -2.36 0.78
Net Income / (Loss) Continuing Operations		 -11 -11 -8.94 -6.58 -4.50 -6.54 -6.15 -4.57 -1.64 -4.33 -4.09
Consolidated Net Income / (Loss)		 -11 -11 -8.94 -6.58 -4.50 -6.54 -6.15 -4.57 -1.64 -4.33 -4.09
Depreciation Expense		 1.57 1.09 0.99 1.09 1.21 1.28 1.37 1.49 1.64 1.62 1.68
Amortization Expense		 -1.55 -1.52 -1.42 -1.19 -1.16 -0.89 -0.79 -0.67 -0.58 -0.54 -0.49
Non-Cash Adjustments To Reconcile Net Income		 8.23 7.50 7.35 7.08 7.59 7.44 8.22 7.65 6.41 6.84 6.27
Changes in Operating Assets and Liabilities, net		 0.44 -3.74 -4.33 -0.09 -1.97 -6.20 -2.47 -1.57 -4.09 -5.95 -2.60
Net Cash From Investing Activities		 -19 6.35 -1.83 3.77 4.34 11 -9.47 -10 13 -6.23 -2.74
Net Cash From Continuing Investing Activities		 -19 6.35 -1.83 3.77 4.34 11 -9.47 -10 13 -6.23 -2.74
Purchase of Property, Plant & Equipment		 -1.09 -2.08 -3.11 -3.04 -2.27 -2.07 -2.10 -2.96 -1.29 -1.08 -1.55
Purchase of Investments		 -62 -59 -51 -61 -35 -47 -51 -59 -35 -51 -42
Sale and/or Maturity of Investments		 44 67 52 68 42 60 44 52 49 46 41
Net Cash From Financing Activities		 0.84 0.11 1.78 0.16 -0.08 0.10 2.23 0.01 1.03 0.03 1.63
Net Cash From Continuing Financing Activities		 0.84 0.11 1.78 0.16 -0.08 0.10 2.23 0.01 1.03 0.03 1.63
Other Financing Activities, net		 0.12 0.11 0.30 0.16 -0.71 0.10 0.67 0.01 0.39 0.03 0.44
Effect of Exchange Rate Changes		 0.15 -0.11 -0.08 0.42 -0.71 0.42 0.03 0.02 -0.03 -0.15 -0.07

Annual Balance Sheets for SiBone

This table presents SiBone's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 36 139 117 223 191 158 230 230 239
Total Current Assets		 34 136 111 218 176 138 211 208 216
Cash & Equivalents		 22 25 10 54 63 21 33 35 42
Short-Term Investments		 0.00 97 81 143 84 77 133 115 106
Accounts Receivable		 7.42 8.49 12 14 14 21 22 27 30
Inventories, net		 2.55 3.34 5.45 5.63 11 17 20 27 34
Prepaid Expenses		 1.25 1.99 2.51 2.57 3.14 2.37 3.17 3.20 4.48
Plant, Property, & Equipment, net		 1.90 2.15 3.95 4.53 8.99 16 16 20 21
Total Noncurrent Assets		 0.31 0.33 1.59 0.37 5.65 4.38 3.03 2.28 1.14
Other Noncurrent Operating Assets		 0.31 0.33 0.32 0.37 5.65 4.38 3.03 2.28 1.14
Total Liabilities & Shareholders' Equity		 36 139 117 223 191 158 230 230 239
Total Liabilities		 47 48 54 54 56 59 61 63 61
Total Current Liabilities		 7.54 9.01 19 13 17 21 23 27 25
Accounts Payable		 1.81 2.15 2.81 3.27 3.20 6.28 4.59 6.49 4.63
Accrued Expenses		 5.72 6.86 12 10 12 14 17 19 20
Other Current Liabilities		 - - - - 1.34 1.39 1.42 1.15 0.94
Total Noncurrent Liabilities		 39 39 35 40 39 38 38 36 36
Long-Term Debt		 39 39 35 39 35 35 36 35 36
Other Noncurrent Operating Liabilities		 0.42 0.36 0.36 0.85 0.06 0.03 0.02 0.01 0.18
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -129 90 63 169 134 98 169 167 178
Total Preferred & Common Equity		 -129 90 63 169 134 98 169 167 178
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -129 90 63 169 134 98 169 167 178
Common Stock		 9.94 247 258 408 430 455 569 598 627
Retained Earnings		 -140 -157 -196 -239 -296 -357 -400 -431 -450
Accumulated Other Comprehensive Income / (Loss)		 0.40 0.44 0.46 0.52 0.35 0.23 0.34 0.24 0.82

Quarterly Balance Sheets for SiBone

This table presents SiBone's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 149 234 231 224 224 227 227 231 234 243 249
Total Current Assets		 128 213 211 204 202 204 204 207 211 215 220
Cash & Equivalents		 23 111 53 32 26 30 41 34 26 34 33
Short-Term Investments		 63 59 113 126 126 121 103 111 119 111 113
Accounts Receivable		 23 20 20 22 25 25 27 24 27 31 31
Inventories, net		 18 21 22 21 23 26 30 34 36 36 38
Prepaid Expenses		 2.05 2.14 1.94 2.65 2.78 2.45 2.70 3.29 2.78 3.54 4.40
Plant, Property, & Equipment, net		 17 18 16 17 19 21 21 22 22 20 22
Total Noncurrent Assets		 4.05 3.71 3.37 2.74 2.40 2.55 2.00 1.77 1.56 7.54 7.13
Other Noncurrent Operating Assets		 4.05 3.71 3.37 2.74 2.40 2.55 2.00 1.77 1.56 7.54 7.13
Total Liabilities & Shareholders' Equity		 149 234 231 224 224 227 227 231 234 243 249
Total Liabilities		 55 56 57 58 59 62 60 61 62 64 66
Total Current Liabilities		 17 18 19 21 22 25 24 25 26 21 24
Accounts Payable		 5.33 6.16 4.42 7.66 7.18 7.32 7.71 7.50 7.72 6.76 8.54
Accrued Expenses		 9.90 11 14 12 13 16 15 16 18 14 15
Other Current Liabilities		 1.40 1.40 1.40 1.43 1.38 1.21 1.09 1.11 1.13 0.66 0.43
Total Noncurrent Liabilities		 38 38 38 37 37 37 36 36 36 42 42
Long-Term Debt		 36 36 36 36 36 36 35 36 36 36 36
Other Noncurrent Operating Liabilities		 0.03 0.02 0.02 0.02 0.01 0.01 0.00 0.00 0.00 6.69 6.74
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 94 177 174 166 165 165 167 170 172 179 182
Total Preferred & Common Equity		 94 177 174 166 165 165 167 170 172 179 182
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 94 177 174 166 165 165 167 170 172 179 182
Common Stock		 462 557 563 577 585 591 605 614 620 633 641
Retained Earnings		 -368 -379 -389 -411 -420 -427 -438 -444 -449 -455 -459
Accumulated Other Comprehensive Income / (Loss)		 0.30 0.30 0.36 0.27 0.23 0.58 0.32 0.66 0.77 0.50 0.39

Annual Metrics And Ratios for SiBone

This table displays calculated financial ratios and metrics derived from SiBone's official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - -
Revenue Growth		 0.00% 15.42% 21.53% 9.04% 22.84% 18.03% 30.52% 20.37% 20.19%
EBITDA Growth		 0.00% 21.45% -194.81% -2.12% -28.44% -16.77% 18.71% 20.19% 46.14%
EBIT Growth		 0.00% 22.90% -174.55% -7.47% -32.82% -15.99% 21.27% 24.89% 36.72%
NOPAT Growth		 0.00% 31.04% -200.90% -7.12% -33.97% -15.36% 21.27% 24.89% 36.65%
Net Income Growth		 0.00% 24.25% -120.04% -13.79% -29.46% -8.28% 29.25% 28.67% 38.85%
EPS Growth		 0.00% 66.92% 29.55% 3.23% -14.00% -4.68% 36.87% 33.63% 41.33%
Operating Cash Flow Growth		 0.00% 17.18% -117.83% 3.05% -28.93% -5.37% 55.08% 33.60% 94.57%
Free Cash Flow Firm Growth		 0.00% 0.00% -178.85% -10.08% -66.71% -7.62% 35.92% -6.52% 24.77%
Invested Capital Growth		 0.00% 26.82% 32.33% 35.03% 114.60% 46.93% 4.81% 30.10% 22.91%
Revenue Q/Q Growth		 0.00% 0.00% 6.63% 3.28% 3.54% 6.74% 5.23% 6.46% 3.80%
EBITDA Q/Q Growth		 0.00% 0.00% -11.16% 2.11% -13.27% 4.69% -4.73% 16.30% 17.06%
EBIT Q/Q Growth		 0.00% 0.00% -11.64% 0.98% -13.15% 4.84% -3.12% 16.59% 11.87%
NOPAT Q/Q Growth		 0.00% 0.00% -13.13% 1.57% -13.29% 4.24% -2.65% 16.59% 11.95%
Net Income Q/Q Growth		 0.00% 0.00% -10.93% 0.27% -10.76% 5.11% 0.44% 17.35% 13.11%
EPS Q/Q Growth		 0.00% 0.00% -2,483.33% 6.25% -11.76% 6.28% 5.04% 17.58% 12.00%
Operating Cash Flow Q/Q Growth		 0.00% -18.64% -9.39% 3.62% -13.92% 12.48% 19.31% 21.86% 44.90%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -0.09% -25.17% 13.87% 12.50% -1.83% 1.85%
Invested Capital Q/Q Growth		 0.00% 0.00% 38.50% 32.06% 50.26% 5.43% -8.50% 3.44% 5.42%
Profitability Metrics		 - - - - - - - - -
Gross Margin		 89.35% 91.27% 89.91% 87.87% 88.43% 85.24% 78.78% 79.03% 79.57%
EBITDA Margin		 -32.74% -22.29% -54.06% -50.63% -52.94% -52.37% -32.62% -21.63% -9.71%
Operating Margin		 -36.16% -21.61% -53.50% -52.55% -57.31% -56.02% -33.79% -21.08% -11.11%
EBIT Margin		 -35.45% -23.68% -53.50% -52.72% -57.01% -56.02% -33.79% -21.08% -11.12%
Profit (Net Income) Margin		 -48.01% -31.52% -57.06% -59.54% -62.75% -57.57% -31.20% -18.49% -9.41%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.22% 99.68% 100.24% 100.00%
Interest Burden Percent		 135.44% 133.09% 106.66% 112.93% 110.08% 102.54% 92.64% 87.49% 84.58%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -222.19% -135.11% -312.97% -250.45% -185.64% -127.15% -82.14% -52.39% -26.34%
ROIC Less NNEP Spread (ROIC-NNEP)		 -289.04% -108.00% -293.71% -234.60% -170.23% -103.77% -70.97% -47.24% -23.44%
Return on Net Nonoperating Assets (RNNOA)		 434.92% 91.13% 262.84% 212.84% 148.40% 74.51% 49.76% 34.01% 15.36%
Return on Equity (ROE)		 212.73% -43.98% -50.13% -37.61% -37.25% -52.64% -32.38% -18.38% -10.97%
Cash Return on Invested Capital (CROIC)		 0.00% -158.76% -340.80% -280.25% -258.50% -165.16% -86.84% -78.56% -46.89%
Operating Return on Assets (OROA)		 -47.47% -15.04% -28.18% -22.75% -24.85% -34.25% -24.19% -15.30% -9.53%
Return on Assets (ROA)		 -64.29% -20.02% -30.06% -25.69% -27.35% -35.20% -22.34% -13.42% -8.06%
Return on Common Equity (ROCE)		 2,541.37% 21.72% -50.13% -37.61% -37.25% -52.64% -32.38% -18.38% -10.97%
Return on Equity Simple (ROE_SIMPLE)		 17.81% -19.35% -60.95% -25.80% -42.09% -62.31% -25.59% -18.51% 0.00%
Net Operating Profit after Tax (NOPAT)		 -12 -8.38 -25 -27 -36 -42 -33 -25 -16
NOPAT Margin		 -25.31% -15.12% -37.45% -36.79% -40.12% -39.21% -23.65% -14.76% -7.78%
Net Nonoperating Expense Percent (NNEP)		 66.85% -27.11% -19.26% -15.84% -15.41% -23.38% -11.17% -5.15% -2.90%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - -30.60% -15.87% -12.14% -7.33%
Cost of Revenue to Revenue		 10.65% 8.73% 10.09% 12.13% 11.57% 14.76% 21.22% 20.97% 20.43%
SG&A Expenses to Revenue		 27.22% 22.82% 31.18% 26.98% 27.81% 27.22% 22.37% 20.19% 20.18%
R&D to Revenue		 11.49% 9.71% 10.82% 12.89% 13.80% 12.81% 10.82% 9.91% 8.68%
Operating Expenses to Revenue		 125.50% 112.88% 143.41% 140.42% 145.75% 141.26% 112.58% 100.11% 90.69%
Earnings before Interest and Taxes (EBIT)		 -17 -13 -36 -39 -51 -60 -47 -35 -22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -16 -12 -36 -37 -48 -56 -45 -36 -20
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 0.00 5.64 8.53 5.71 5.53 4.77 5.02 3.52 4.82
Price to Tangible Book Value (P/TBV)		 0.00 5.64 8.53 5.71 5.53 4.77 5.02 3.52 4.82
Price to Revenue (P/Rev)		 2.25 9.18 7.99 13.18 8.25 4.41 6.12 3.52 4.26
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 44.43 61.33 52.74 65.45 23.93 10.50 17.63 8.91 11.36
Enterprise Value to Revenue (EV/Rev)		 5.06 7.68 7.19 11.05 7.05 3.85 5.20 2.84 3.70
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 -3.57 0.43 0.62 0.23 0.29 0.39 0.22 0.22 0.20
Long-Term Debt to Equity		 -3.57 0.43 0.55 0.23 0.29 0.39 0.22 0.22 0.20
Financial Leverage		 -1.50 -0.84 -0.89 -0.91 -0.87 -0.72 -0.70 -0.72 -0.66
Leverage Ratio		 -3.31 2.20 1.67 1.46 1.36 1.50 1.45 1.37 1.36
Compound Leverage Factor		 -4.48 2.92 1.78 1.65 1.50 1.53 1.34 1.20 1.15
Debt to Total Capital		 138.85% 30.17% 38.37% 18.89% 22.55% 27.90% 18.16% 17.87% 16.76%
Short-Term Debt to Total Capital		 0.00% 0.00% 4.26% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 138.85% 30.17% 34.10% 18.89% 22.55% 27.90% 18.16% 17.87% 16.76%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 425.30% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 -464.15% 69.83% 61.63% 81.11% 77.45% 72.10% 81.84% 82.13% 83.24%
Debt to EBITDA		 -2.46 -3.16 -1.08 -1.06 -0.82 -0.68 -0.83 -1.00 -1.83
Net Debt to EBITDA		 -1.04 6.75 1.48 4.22 2.26 1.06 2.84 3.15 5.74
Long-Term Debt to EBITDA		 -2.46 -3.16 -0.96 -1.06 -0.82 -0.68 -0.83 -1.00 -1.83
Debt to NOPAT		 -3.19 -4.65 -1.56 -1.46 -1.08 -0.91 -1.14 -1.47 -2.29
Net Debt to NOPAT		 -1.34 9.94 2.14 5.81 2.98 1.42 3.91 4.61 7.17
Long-Term Debt to NOPAT		 -3.19 -4.65 -1.38 -1.46 -1.08 -0.91 -1.14 -1.47 -2.29
Altman Z-Score		 -3.42 5.91 4.14 10.15 6.37 1.89 6.83 4.10 7.26
Noncontrolling Interest Sharing Ratio		 -1,094.63% 149.38% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - -
Current Ratio		 4.46 15.11 5.94 16.20 10.41 6.50 9.01 7.66 8.55
Quick Ratio		 3.96 14.51 5.51 15.59 9.55 5.57 8.01 6.54 7.03
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -9.84 -27 -30 -50 -54 -35 -37 -28
Operating Cash Flow to CapEx		 -3,667.36% -1,541.30% -1,293.54% -1,197.27% -618.77% -438.15% -239.94% -118.37% -8.02%
Free Cash Flow to Firm to Interest Expense		 0.00 -1.93 -5.55 -4.95 -9.39 -19.23 -10.03 -10.75 -10.59
Operating Cash Flow to Interest Expense		 -2.83 -2.84 -6.39 -5.03 -7.37 -14.78 -5.41 -3.61 -0.26
Operating Cash Flow Less CapEx to Interest Expense		 -2.90 -3.03 -6.88 -5.45 -8.56 -18.15 -7.66 -6.66 -3.46
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 1.34 0.64 0.53 0.43 0.44 0.61 0.72 0.73 0.86
Accounts Receivable Turnover		 6.47 6.97 6.66 5.79 6.47 6.09 6.52 6.77 7.00
Inventory Turnover		 2.00 1.64 1.54 1.61 1.22 1.09 1.57 1.48 1.35
Fixed Asset Turnover		 25.31 27.35 22.04 17.31 13.34 8.67 8.80 9.19 9.64
Accounts Payable Turnover		 2.82 2.44 2.74 2.93 3.22 3.31 5.42 6.33 7.38
Days Sales Outstanding (DSO)		 56.41 52.40 54.79 62.99 56.39 59.89 56.01 53.94 52.11
Days Inventory Outstanding (DIO)		 182.29 222.64 236.39 227.25 299.81 334.44 232.45 246.35 271.09
Days Payable Outstanding (DPO)		 129.52 149.53 133.23 124.69 113.21 110.13 67.31 57.66 49.44
Cash Conversion Cycle (CCC)		 109.18 125.51 157.95 165.56 242.99 284.20 221.16 242.64 273.77
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 5.47 6.93 9.17 12 27 39 41 53 65
Invested Capital Turnover		 8.78 8.93 8.36 6.81 4.63 3.24 3.47 3.55 3.39
Increase / (Decrease) in Invested Capital		 0.00 1.47 2.24 3.21 14 12 1.88 12 12
Enterprise Value (EV)		 243 425 484 811 636 410 722 474 744
Market Capitalization		 108 508 538 968 744 469 850 588 856
Book Value per Share		 ($37.32) $3.71 $2.52 $5.23 $4.01 $2.85 $4.18 $3.98 $4.09
Tangible Book Value per Share		 ($37.32) $3.71 $2.52 $5.23 $4.01 $2.85 $4.18 $3.98 $4.09
Total Capital		 28 129 102 209 174 136 207 203 213
Total Debt		 39 39 39 39 39 38 38 36 36
Total Long-Term Debt		 39 39 35 39 39 38 38 36 36
Net Debt		 16 -83 -54 -157 -108 -59 -128 -114 -112
Capital Expenditures (CapEx)		 0.48 0.94 2.45 2.56 6.39 9.51 7.80 10 8.41
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 3.68 4.81 5.27 8.34 12 19 22 31 43
Debt-free Net Working Capital (DFNWC)		 26 127 97 205 159 116 188 181 191
Net Working Capital (NWC)		 26 127 93 205 159 116 188 181 191
Net Nonoperating Expense (NNE)		 11 9.08 13 17 20 20 10 6.24 3.27
Net Nonoperating Obligations (NNO)		 16 -83 -54 -157 -108 -59 -128 -114 -112
Total Depreciation and Amortization (D&A)		 1.30 0.77 -0.38 1.54 3.67 3.88 1.63 -0.91 2.84
Debt-free, Cash-free Net Working Capital to Revenue		 7.68% 8.69% 7.82% 11.36% 13.31% 17.99% 15.78% 18.31% 21.41%
Debt-free Net Working Capital to Revenue		 54.38% 229.39% 144.20% 279.03% 176.34% 109.42% 135.32% 108.06% 94.98%
Net Working Capital to Revenue		 54.38% 229.39% 137.72% 279.03% 176.34% 109.42% 135.32% 108.06% 94.98%
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 ($6.65) ($2.20) ($1.55) ($1.50) ($1.71) ($1.79) ($1.13) ($0.75) ($0.44)
Adjusted Weighted Average Basic Shares Outstanding		 3.47M 24.46M 28.38M 32.73M 33.15M 34.20M 38.43M 41.47M 42.96M
Adjusted Diluted Earnings per Share		 ($6.65) ($2.20) ($1.55) ($1.50) ($1.71) ($1.79) ($1.13) ($0.75) ($0.44)
Adjusted Weighted Average Diluted Shares Outstanding		 3.47M 24.46M 28.38M 32.73M 33.15M 34.20M 38.43M 41.47M 42.96M
Adjusted Basic & Diluted Earnings per Share		 ($6.65) ($2.20) ($1.55) ($1.50) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 3.47M 7.95M 24.71M 29.06M 33.84M 34.99M 41.06M 42.45M 44.17M
Normalized Net Operating Profit after Tax (NOPAT)		 -12 -8.38 -25 -27 -36 -42 -33 -25 -16
Normalized NOPAT Margin		 -25.31% -15.12% -37.45% -36.79% -40.12% -39.21% -23.65% -14.76% -7.78%
Pre Tax Income Margin		 -48.01% -31.52% -57.06% -59.54% -62.75% -57.44% -31.30% -18.45% -9.41%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 -2.74 -2.57 -7.28 -6.34 -9.58 -21.15 -13.56 -10.25 -8.50
NOPAT to Interest Expense		 -1.96 -1.64 -5.09 -4.43 -6.74 -14.80 -9.49 -7.17 -5.95
EBIT Less CapEx to Interest Expense		 -2.82 -2.75 -7.77 -6.76 -10.77 -24.52 -15.81 -13.30 -11.71
NOPAT Less CapEx to Interest Expense		 -2.03 -1.82 -5.59 -4.84 -7.93 -18.17 -11.74 -10.22 -9.15
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -5.61% -11.29% -0.43% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for SiBone

This table displays calculated financial ratios and metrics derived from SiBone's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 44,165,287.00 44,349,283.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 44,165,287.00 44,349,283.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - -0.10 -0.09
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 21.61% 15.77% 20.01% 18.60% 26.10% 24.88% 21.67% 20.61% 14.99% 11.20% 15.18%
EBITDA Growth		 -17.29% -17.80% 7.06% 29.01% 56.41% 43.65% 38.73% 40.94% 74.09% 43.37% 43.58%
EBIT Growth		 -10.73% -8.17% 15.61% 32.52% 56.07% 38.43% 30.45% 29.42% 55.09% 31.85% 31.17%
NOPAT Growth		 -10.73% -6.64% 15.76% 31.66% 56.07% 37.89% 30.50% 29.48% 55.17% 31.91% 31.38%
Net Income Growth		 1.72% 1.99% 20.23% 34.39% 59.07% 40.00% 31.18% 30.56% 63.43% 33.75% 33.55%
EPS Growth		 18.75% 15.63% 26.67% 36.00% 61.54% 44.44% 36.36% 31.25% 60.00% 33.33% 35.71%
Operating Cash Flow Growth		 66.10% 29.59% -76.43% 114.57% 151.28% 35.13% 102.73% 673.18% 46.69% 51.90% 349.13%
Free Cash Flow Firm Growth		 47.83% 70.57% 42.99% 22.03% -52.06% -173.84% -37.39% -18.86% 13.87% 24.18% 3.38%
Invested Capital Growth		 4.81% -3.10% 8.82% 15.09% 30.10% 30.88% 20.67% 20.60% 22.91% 18.58% 18.82%
Revenue Q/Q Growth		 14.24% -2.55% 5.55% 0.93% 21.47% -3.49% 2.83% 0.05% 15.81% -6.67% 6.51%
EBITDA Q/Q Growth		 -14.46% -2.19% 16.47% 26.26% 29.71% -30.14% 9.17% 28.98% 69.20% -185.00% 9.50%
EBIT Q/Q Growth		 -10.56% 1.50% 16.99% 24.23% 28.02% -36.00% 6.24% 23.17% 54.24% -106.74% 5.30%
NOPAT Q/Q Growth		 -11.97% 3.70% 16.32% 24.26% 28.02% -36.15% 6.36% 23.14% 54.24% -106.78% 5.64%
Net Income Q/Q Growth		 -9.59% 0.72% 18.02% 26.45% 31.64% -45.54% 5.96% 25.78% 63.99% -163.63% 5.68%
EPS Q/Q Growth		 -4.00% -3.85% 18.52% 27.27% 37.50% -50.00% 6.67% 21.43% 63.64% -150.00% 10.00%
Operating Cash Flow Q/Q Growth		 -10.81% -229.60% 16.34% 104.77% 290.07% -516.89% 103.52% 1,249.71% -26.00% -236.69% 132.90%
Free Cash Flow Firm Q/Q Growth		 31.44% 34.27% -59.24% -8.67% -33.70% -18.37% 20.11% 5.99% 3.12% -4.20% -1.81%
Invested Capital Q/Q Growth		 -8.50% 9.97% 11.61% 2.47% 3.44% 10.63% 2.91% 2.41% 5.42% 6.73% 3.11%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 73.80% 78.87% 79.00% 79.09% 79.13% 79.71% 79.80% 79.84% 79.03% 79.76% 79.54%
EBITDA Margin		 -32.12% -33.18% -26.26% -19.19% -11.10% -14.97% -13.23% -9.39% -2.50% -7.63% -6.48%
Operating Margin		 -32.18% -31.80% -25.21% -18.92% -11.21% -15.82% -14.40% -11.06% -4.37% -9.68% -8.58%
EBIT Margin		 -32.18% -32.05% -25.20% -18.92% -11.21% -15.80% -14.41% -11.06% -4.37% -9.68% -8.61%
Profit (Net Income) Margin		 -28.26% -28.80% -22.36% -16.30% -9.17% -13.83% -12.65% -9.38% -2.92% -8.24% -7.30%
Tax Burden Percent		 98.73% 100.00% 100.00% 99.91% 101.79% 100.00% 100.00% 100.62% 98.33% 100.00% 100.00%
Interest Burden Percent		 88.95% 89.85% 88.73% 86.22% 80.38% 87.55% 87.81% 84.30% 67.88% 85.11% 84.78%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -78.23% -70.12% -55.18% -43.23% -27.86% -37.63% -33.69% -26.40% -10.36% -21.71% -19.34%
ROIC Less NNEP Spread (ROIC-NNEP)		 -75.86% -67.17% -53.65% -42.22% -27.33% -36.49% -32.58% -25.69% -10.43% -21.01% -18.68%
Return on Net Nonoperating Assets (RNNOA)		 53.19% 43.49% 38.53% 30.22% 19.67% 25.09% 21.80% 17.03% 6.84% 13.19% 11.66%
Return on Equity (ROE)		 -25.04% -26.62% -16.65% -13.01% -8.19% -12.54% -11.89% -9.37% -3.52% -8.52% -7.69%
Cash Return on Invested Capital (CROIC)		 -86.84% -69.83% -74.95% -75.52% -78.56% -68.08% -53.60% -49.94% -46.89% -38.68% -35.92%
Operating Return on Assets (OROA)		 -23.04% -24.77% -16.60% -12.98% -8.13% -12.37% -11.74% -9.29% -3.75% -8.50% -7.67%
Return on Assets (ROA)		 -20.24% -22.25% -14.73% -11.18% -6.66% -10.83% -10.31% -7.88% -2.50% -7.23% -6.50%
Return on Common Equity (ROCE)		 -25.04% -26.62% -16.65% -13.01% -8.19% -12.54% -11.89% -9.37% -3.52% -8.52% -7.69%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -26.05% -24.80% -22.67% 0.00% -15.87% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -8.75 -8.43 -7.05 -5.34 -3.85 -5.24 -4.90 -3.77 -1.72 -3.57 -3.36
NOPAT Margin		 -22.53% -22.26% -17.65% -13.25% -7.85% -11.07% -10.08% -7.74% -3.06% -6.78% -6.01%
Net Nonoperating Expense Percent (NNEP)		 -2.38% -2.94% -1.53% -1.02% -0.54% -1.14% -1.11% -0.71% 0.07% -0.71% -0.66%
Return On Investment Capital (ROIC_SIMPLE)		 -4.23% - - - -1.89% -2.58% -2.38% -1.81% -0.81% -1.66% -1.54%
Cost of Revenue to Revenue		 26.21% 21.13% 21.00% 20.91% 20.87% 20.29% 20.20% 20.16% 20.97% 20.24% 20.46%
SG&A Expenses to Revenue		 20.80% 21.59% 20.85% 20.07% 18.68% 21.06% 22.05% 20.62% 17.44% 19.09% 18.05%
R&D to Revenue		 10.71% 11.47% 10.89% 9.90% 7.90% 9.59% 8.86% 8.72% 7.74% 7.97% 9.32%
Operating Expenses to Revenue		 105.98% 110.67% 104.22% 98.01% 90.35% 95.53% 94.20% 90.90% 83.40% 89.44% 88.12%
Earnings before Interest and Taxes (EBIT)		 -13 -12 -10 -7.63 -5.49 -7.47 -7.01 -5.38 -2.46 -5.09 -4.82
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -12 -13 -10 -7.74 -5.44 -7.08 -6.43 -4.57 -1.41 -4.01 -3.63
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.02 4.01 3.23 3.53 3.52 3.56 4.71 3.69 4.82 3.12 3.97
Price to Tangible Book Value (P/TBV)		 5.02 4.01 3.23 3.53 3.52 3.56 4.71 3.69 4.82 3.12 3.97
Price to Revenue (P/Rev)		 6.12 4.60 3.54 3.71 3.52 3.37 4.33 3.28 4.26 2.70 3.39
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 17.63 12.05 8.33 9.12 8.91 8.27 11.42 8.46 11.36 6.42 8.52
Enterprise Value to Revenue (EV/Rev)		 5.20 3.77 2.78 2.99 2.84 2.76 3.74 2.71 3.70 2.18 2.87
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 239.45 247.57
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.22 0.23 0.22 0.23 0.22 0.22 0.21 0.21 0.20 0.20 0.20
Long-Term Debt to Equity		 0.22 0.23 0.22 0.23 0.22 0.22 0.21 0.21 0.20 0.20 0.20
Financial Leverage		 -0.70 -0.65 -0.72 -0.72 -0.72 -0.69 -0.67 -0.66 -0.66 -0.63 -0.62
Leverage Ratio		 1.45 1.44 1.34 1.35 1.37 1.36 1.36 1.37 1.36 1.36 1.36
Compound Leverage Factor		 1.29 1.29 1.19 1.17 1.10 1.19 1.19 1.15 0.92 1.16 1.15
Debt to Total Capital		 18.16% 18.39% 18.36% 18.45% 17.87% 17.74% 17.38% 17.18% 16.76% 16.59% 16.35%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 18.16% 18.39% 18.36% 18.45% 17.87% 17.74% 17.38% 17.18% 16.76% 16.59% 16.35%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 81.84% 81.61% 81.64% 81.55% 82.13% 82.26% 82.62% 82.82% 83.24% 83.41% 83.66%
Debt to EBITDA		 -0.83 -0.79 -0.80 -0.86 -1.00 -1.17 -1.34 -1.52 -1.83 -2.17 -2.61
Net Debt to EBITDA		 2.84 2.56 2.47 2.63 3.15 3.52 4.11 4.68 5.74 6.63 8.09
Long-Term Debt to EBITDA		 -0.83 -0.79 -0.80 -0.86 -1.00 -1.17 -1.34 -1.52 -1.83 -2.17 -2.61
Debt to NOPAT		 -1.14 -1.12 -1.16 -1.26 -1.47 -1.68 -1.85 -2.01 -2.29 -2.55 -2.87
Net Debt to NOPAT		 3.91 3.61 3.57 3.84 4.61 5.04 5.68 6.20 7.17 7.81 8.88
Long-Term Debt to NOPAT		 -1.14 -1.12 -1.16 -1.26 -1.47 -1.68 -1.85 -2.01 -2.29 -2.55 -2.87
Altman Z-Score		 7.32 5.71 4.27 4.53 4.52 4.88 6.90 5.14 7.54 4.36 5.70
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 9.01 9.76 9.17 8.25 7.66 8.53 8.38 7.97 8.55 9.99 9.15
Quick Ratio		 8.01 8.63 7.99 7.12 6.54 7.14 6.87 6.52 7.03 8.17 7.37
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -11 -6.99 -11 -12 -16 -19 -15 -14 -14 -15 -15
Operating Cash Flow to CapEx		 -210.16% -363.64% -203.47% 9.95% 51.99% -237.02% 8.24% 79.02% 134.16% -219.31% 50.29%
Free Cash Flow to Firm to Interest Expense		 -11.95 -7.93 -12.65 -13.68 -20.34 -28.91 -22.95 -21.45 -22.10 -24.51 -24.70
Operating Cash Flow to Interest Expense		 -2.58 -8.59 -7.20 0.34 1.48 -7.42 0.26 3.49 2.74 -3.99 1.30
Operating Cash Flow Less CapEx to Interest Expense		 -3.81 -10.96 -10.74 -3.09 -1.37 -10.55 -2.89 -0.93 0.70 -5.81 -1.28
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.72 0.77 0.66 0.69 0.73 0.78 0.81 0.84 0.86 0.88 0.89
Accounts Receivable Turnover		 6.52 6.44 6.67 7.00 6.77 7.24 7.54 7.53 7.00 7.15 7.69
Inventory Turnover		 1.57 1.62 1.54 1.46 1.48 1.43 1.33 1.29 1.35 1.28 1.20
Fixed Asset Turnover		 8.80 8.48 8.22 8.43 9.19 9.19 9.08 9.07 9.64 9.93 9.84
Accounts Payable Turnover		 5.42 4.86 5.04 5.97 6.33 4.77 5.19 5.25 7.38 5.82 5.46
Days Sales Outstanding (DSO)		 56.01 56.64 54.76 52.18 53.94 50.44 48.43 48.50 52.11 51.03 47.46
Days Inventory Outstanding (DIO)		 232.45 224.71 237.66 249.41 246.35 256.09 275.47 283.30 271.09 285.76 303.10
Days Payable Outstanding (DPO)		 67.31 75.17 72.40 61.18 57.66 76.52 70.33 69.58 49.44 62.72 66.90
Cash Conversion Cycle (CCC)		 221.16 206.18 220.02 240.41 242.64 230.02 253.57 262.22 273.77 274.08 283.66
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 41 45 50 51 53 59 61 62 65 70 72
Invested Capital Turnover		 3.47 3.15 3.13 3.26 3.55 3.40 3.34 3.41 3.39 3.20 3.22
Increase / (Decrease) in Invested Capital		 1.88 -1.44 4.07 6.75 12 14 10 11 12 11 11
Enterprise Value (EV)		 722 542 418 469 474 487 692 525 744 449 613
Market Capitalization		 850 663 533 583 588 596 802 635 856 558 724
Book Value per Share		 $4.18 $4.04 $4.00 $3.96 $3.98 $3.94 $4.00 $3.99 $4.09 $4.05 $4.11
Tangible Book Value per Share		 $4.18 $4.04 $4.00 $3.96 $3.98 $3.94 $4.00 $3.99 $4.09 $4.05 $4.11
Total Capital		 207 203 202 202 203 203 206 208 213 215 218
Total Debt		 38 37 37 37 36 36 36 36 36 36 36
Total Long-Term Debt		 38 37 37 37 36 36 36 36 36 36 36
Net Debt		 -128 -121 -114 -113 -114 -108 -110 -110 -112 -109 -110
Capital Expenditures (CapEx)		 1.09 2.08 3.11 3.04 2.27 2.07 2.10 2.96 1.29 1.08 1.55
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 22 25 29 28 31 36 37 39 43 49 50
Debt-free Net Working Capital (DFNWC)		 188 183 180 179 181 180 183 184 191 193 196
Net Working Capital (NWC)		 188 183 180 179 181 180 183 184 191 193 196
Net Nonoperating Expense (NNE)		 2.23 2.47 1.88 1.23 0.65 1.31 1.25 0.80 -0.08 0.77 0.72
Net Nonoperating Obligations (NNO)		 -128 -121 -114 -113 -114 -108 -110 -110 -112 -109 -110
Total Depreciation and Amortization (D&A)		 0.02 -0.43 -0.42 -0.11 0.05 0.39 0.57 0.82 1.06 1.08 1.19
Debt-free, Cash-free Net Working Capital to Revenue		 15.78% 17.32% 19.07% 17.96% 18.31% 20.29% 20.06% 19.94% 21.41% 23.54% 23.37%
Debt-free Net Working Capital to Revenue		 135.32% 126.88% 119.62% 114.00% 108.06% 102.07% 98.62% 95.23% 94.98% 93.70% 91.70%
Net Working Capital to Revenue		 135.32% 126.88% 119.62% 114.00% 108.06% 102.07% 98.62% 95.23% 94.98% 93.70% 91.70%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.26) ($0.27) ($0.22) ($0.16) ($0.10) ($0.15) ($0.14) ($0.11) ($0.04) ($0.10) ($0.09)
Adjusted Weighted Average Basic Shares Outstanding		 38.43M 40.93M 41.32M 41.72M 41.47M 42.34M 42.79M 43.19M 42.96M 43.96M 44.48M
Adjusted Diluted Earnings per Share		 ($0.26) ($0.27) ($0.22) ($0.16) ($0.10) ($0.15) ($0.14) ($0.11) ($0.04) ($0.10) ($0.09)
Adjusted Weighted Average Diluted Shares Outstanding		 38.43M 40.93M 41.32M 41.72M 41.47M 42.34M 42.79M 43.19M 42.96M 43.96M 44.48M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 41.06M 41.20M 41.69M 41.94M 42.45M 42.61M 43.14M 43.39M 44.17M 44.35M 44.82M
Normalized Net Operating Profit after Tax (NOPAT)		 -8.75 -8.43 -7.05 -5.34 -3.85 -5.24 -4.90 -3.77 -1.72 -3.57 -3.36
Normalized NOPAT Margin		 -22.53% -22.26% -17.65% -13.25% -7.85% -11.07% -10.08% -7.74% -3.06% -6.78% -6.01%
Pre Tax Income Margin		 -28.63% -28.80% -22.36% -16.31% -9.01% -13.83% -12.65% -9.33% -2.97% -8.24% -7.30%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -14.05 -13.78 -11.45 -8.63 -6.91 -11.29 -10.52 -8.03 -3.91 -8.60 -8.06
NOPAT to Interest Expense		 -9.84 -9.57 -8.02 -6.04 -4.84 -7.91 -7.36 -5.62 -2.74 -6.02 -5.63
EBIT Less CapEx to Interest Expense		 -15.28 -16.14 -14.99 -12.07 -9.76 -14.42 -13.67 -12.44 -5.95 -10.42 -10.65
NOPAT Less CapEx to Interest Expense		 -11.06 -11.93 -11.55 -9.48 -7.69 -11.04 -10.51 -10.03 -4.78 -7.84 -8.21
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

SI-BONE’s latest results show improving revenue, but the company is still not profitable and continues to burn cash. In Q4 2025, revenue rose to $56.3 million from $48.7 million in Q3 2025 and $49.0 million in Q4 2024. However, operating losses widened versus the prior-year quarter, and quarterly earnings remained negative.

  • Revenue is trending higher. Q4 2025 revenue increased 15.8% year over year, and full-year quarterly revenue has generally moved up from the low-$30 million range in early 2023 to the mid-$50 million range by late 2025.
  • Gross profit remains strong. Q4 2025 gross profit was $44.5 million, representing a gross margin of roughly 79%, which indicates the core business still has attractive product economics.
  • Operating cash flow turned positive. SI-BONE generated $1.7 million in operating cash flow in Q4 2025, compared with $2.3 million in Q3 2025 and a negative $4.9 million in Q1 2025.
  • Liquidity remains solid. At the end of Q3 2025, the company had $26.5 million in cash and $119.3 million in short-term investments, giving it substantial near-term financial flexibility.
  • Balance sheet equity improved. Total common equity rose to $172.1 million in Q3 2025 from $167.3 million in Q1 2025, supported by retained earnings improvement and ongoing capital raises over time.
  • Investing activity reflects a large securities portfolio. Cash flow has been influenced by sales and purchases of investments, which can create quarter-to-quarter volatility in cash movement.
  • Share count has drifted higher over time. Weighted average shares outstanding were about 42.96 million in Q4 2025 versus 40.93 million in Q1 2024, which can dilute per-share results.
  • Interest and investment income helps offset losses. The company continues to generate meaningful non-operating income, but it is not enough to fully cover operating expenses.
  • The company remains unprofitable. SI-BONE reported a Q4 2025 net loss of $1.6 million, and losses were larger in Q3 2025 at $4.6 million and Q2 2025 at $6.2 million.
  • Operating losses are still significant. Q4 2025 operating loss was $2.5 million, and Q3 2025 operating loss was $5.4 million, showing the business has not yet reached consistent operating profitability.
  • Marketing spend is very high. In Q4 2025, marketing expense was $32.8 million, far larger than SG&A and R&D, keeping total operating expenses elevated.
  • Cash generation remains uneven. Operating cash flow was positive in the last two quarters of 2025, but earlier periods were negative, highlighting that cash flow has not yet stabilized.

Bottom line: SI-BONE looks like a growth story with improving revenue and strong gross margins, but investors should still focus on whether management can convert that growth into durable operating profitability. For now, the company appears to have adequate liquidity, but its heavy marketing spend and recurring losses remain the main risks.

08/23/26 11:54 AM ETAI Generated. May Contain Errors.

SiBone Financials - Frequently Asked Questions

According to the most recent income statement we have on file, SiBone's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

SiBone's net income appears to be on an upward trend, with a most recent value of -$18.90 million in 2025, falling from -$23.04 million in 2017. The previous period was -$30.91 million in 2024. See where experts think SiBone is headed by visiting SiBone's forecast page.

SiBone's total operating income in 2025 was -$22.33 million, based on the following breakdown:
  • Total Gross Profit: $159.88 million
  • Total Operating Expenses: $182.21 million

Over the last 8 years, SiBone's total revenue changed from $47.98 million in 2017 to $200.93 million in 2025, a change of 318.7%.

SiBone's total liabilities were at $61.02 million at the end of 2025, a 3.9% decrease from 2024, and a 30.8% increase since 2017.

In the past 8 years, SiBone's cash and equivalents has ranged from $10.44 million in 2019 to $63.42 million in 2021, and is currently $42.24 million as of their latest financial filing in 2025.

Over the last 8 years, SiBone's book value per share changed from -37.32 in 2017 to 4.09 in 2025, a change of -111.0%.


Related Companies

Financial statements for NASDAQ:SIBN last updated on 8/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel